US90328M1071
US90328M1071
USANA Health Sciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 925.257.000 | 854.503.000 | 8.3% |
| Cost of Revenue | 200.852.000 | 161.212.000 | 24.6% |
| Gross Profit | 724.405.000 | 693.291.000 | 4.5% |
| 673.543.000 | 626.967.000 | 7.4% | |
| Operating Income | 50.862.000 | 66.324.000 | 23.3% |
| Pretax Income | 41.527.000 | 76.351.000 | 45.6% |
| Net Income Common Stockholders | 10.760.000 | 42.030.000 | 74.4% |
| -- | -- | -- | |
| -- | -- | -- |